Related Experiment Video

Updated: Jul 18, 2026

Light-mediated Reversible Modulation of the Mitogen-activated Protein Kinase Pathway during Cell Differentiation and Xenopus Embryonic Development
09:32

Light-mediated Reversible Modulation of the Mitogen-activated Protein Kinase Pathway during Cell Differentiation and Xenopus Embryonic Development

Published on: June 15, 2017

RACK1 regulates Ki-Ras-mediated signaling and morphological transformation of NIH 3T3 cells

Bodil Bjørndal1, Line M Myklebust, Ken Roger Rosendal

  • 1Department of Molecular Biology, University of Bergen, Bergen, Norway.

International Journal of Cancer
|December 7, 2006
PubMed

Insights

A truncated protein, RACK1DeltaWD1, inhibits Ras-mediated cancer cell transformation by disrupting signaling pathways. This discovery offers potential new targets for cancer therapy.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Oncology

Background:

  • Activating Ras mutations drive a significant proportion of human cancers.
  • Understanding Ras-mediated transformation requires identifying novel regulatory factors.

Purpose of the Study:

  • To identify novel inhibitors of Ras-mediated transformation.
  • To characterize the role of a truncated RACK1 protein (RACK1DeltaWD1) in Ras signaling.

Main Methods:

  • Conducted a retroviral mouse fibroblast cDNA library suppressor screen.
  • Expressed RACK1DeltaWD1 in Ki-Ras transformed NIH 3T3 cells.
  • Analyzed cell morphology, contact inhibition, stress fiber formation, ERK phosphorylation, and protein complex formation.

Main Results:

  • Identified RACK1DeltaWD1 as a potent inhibitor of Ras-mediated morphological transformation.
  • RACK1DeltaWD1 expression restored normal cell characteristics and reduced ERK phosphorylation.
  • Demonstrated RACK1DeltaWD1 disrupts signaling complexes involving wild-type RACK1 and Protein Kinase C (PKC) isoforms, impairing Ras signal transduction to the Raf-MEK-ERK pathway.

Conclusions:

  • RACK1 acts as a key factor in Ki-Ras-mediated morphological transformation.
  • RACK1DeltaWD1 inhibits transformation by interfering with RACK1/PKC signaling complex formation and localization.
  • These findings suggest RACK1 and its truncated forms as potential therapeutic targets in Ras-driven cancers.

More Related Videos

Spatio-Temporal Manipulation of Small GTPase Activity at Subcellular Level and on Timescale of Seconds in Living Cells10:27

Spatio-Temporal Manipulation of Small GTPase Activity at Subcellular Level and on Timescale of Seconds in Living Cells

Published on: March 9, 2012

Focus Formation: A Cell-based Assay to Determine the Oncogenic Potential of a Gene08:18

Focus Formation: A Cell-based Assay to Determine the Oncogenic Potential of a Gene

Published on: December 31, 2014

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...